Related Experiment Video
Updated: Mar 10, 2026
10:54
Conventional Repetitive Transcranial Magnetic Stimulation for Depression: A Step-by-Step Protocol
Published on: November 21, 2025
686
[Tailored pharmacotherapy. Consultations about medication in a care programme for depression]
Tijdschrift Voor Psychiatrie
|December 16, 2016
Summary
For depression treatment, approximately five to six psychiatrist consultations are typically sufficient for medication management during the acute phase. Additional sessions may be needed for less stable or crisis-prone individuals requiring ongoing psychiatric care.
Area of Science:
- Psychiatry
- Mental Health Care
- Pharmacotherapy
Background:
- Lack of specific guidelines for psychiatrist contact frequency in combined depression treatment.
- Increasing rationalization of mental health services.
Purpose of the Study:
- To explore the development of advisory recommendations for consultation frequency, number, and duration in depression pharmacotherapy.
- To address the need for evidence-based guidance in outpatient mental health care.
Main Methods:
- Comprehensive literature review on depression treatment.
- Qualitative interviews with psychiatrists and psychiatric residents.
Main Results:
- Literature primarily addresses diagnostics and patient factors influencing care needs.
- Expert advice is key for pharmacotherapy recommendations.
- Psychiatric practice reveals numerous factors affecting consultation frequency and duration, yet a discernible pattern exists.
Conclusions:
- Five to six psychiatrist visits are generally adequate for medication management in the acute phase of depression.
- Less stable patients and those prone to crises may require additional consultations.
- The findings support the development of advisory documents for optimizing psychiatric care.
More Related Videos
Related Concept Videos
01:28Drug Therapy
360
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
360
01:26Psychosis: Goals of Pharmacotherapy
646
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
646
01:25Antidepressant Drugs: Overview
1.8K
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
1.8K
01:28Dosage Regimens: Designs and Approaches
411
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
411
01:29Therapeutic Drug Monitoring: Affecting Factors
306
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
306
01:16Therapeutic Drug Monitoring: Overview and Classification
465
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
465